老香山品牌怎么样 申请店铺

我要投票 老香山在中草药行业中的票数:101 更新时间:2025-02-06
老香山是哪个国家的品牌?「老香山」是 华润温州医药有限公司 旗下著名品牌。该品牌发源于浙江,由创始人陈梅在1996-03-04期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
老香山怎么样

浙江温州医药商业集团有限公司是浙江温州医药商业集团的核心层企业,由创建于1953年9月的浙江省温州医药采购供应站整体改组而成,注册资金5000万元,系国有独资企业性质。一直以来为人民群众防病治病、康复保健、计划生育等及时提供安全有效的医药商品和优质服务。该集团公司是国家级GSP认证企业、中国质量服务信誉AAA级企业、浙江省医药商业重点企业与温州市“百强企业”。

该集团公司主要经营中药材、中药饮片、中成药、化学原料药、化学药制剂、抗生素、生化药品、生物制品、医疗器械、化学试剂、玻璃仪器、中药配方等十几大类医药商品,购销客户达3000余家,遍及全国各省、市、自治区。销售网络覆盖浙江省杭州、宁波、温州、台州、金华、丽水及福建省福州、宁德、福安、拓荣等地区。承担着浙江省疫情、灾情防治药械的储备和应急供应重任,是浙江省定点的3家药械储备企业之一。

该集团公司(含紧密层子公司)近1000名员工为实行医药商品的调、批、零一体化、集约化、连锁化和多元化经营而努力工作。现有8个职能处室;5个医药专业分公司;3个全资创办的子公司。拥有“老香山”、“鹿威”等注册字号与品牌,商誉良好。

经过五十多年的长足发展,该集团公司已成为经济实力、综合经营能力较强,药学力量雄厚的国有大型贸易企业。该集团公司将本着“团结、求实、优质、高效、创新”的企业精神,面向未来,不断增强企业自主创新能力,努力打造温州医药商业的航母,进一步提升综合竞争力,为实践发展活力温州、提升实力温州、构建和谐温州而积极作出新贡献!

Zhejiang Wenzhou Pharmaceutical Business Group Co., Ltd. is the core enterprise of Zhejiang Wenzhou pharmaceutical business group. It is a wholly state-owned enterprise with a registered capital of 50 million yuan, which was reorganized from Wenzhou pharmaceutical purchase and supply station of Zhejiang Province founded in September 1953. It has been providing people with safe and effective medical commodities and high-quality services in time for disease prevention and treatment, rehabilitation and health care, family planning, etc. The group is a state-level GSP certification enterprise, China's AAA quality service reputation enterprise, Zhejiang Province pharmaceutical business key enterprise and Wenzhou "top 100 enterprises". The group mainly deals in more than ten categories of pharmaceutical products, such as Chinese medicinal materials, Chinese herbal pieces, Chinese patent medicines, chemical raw materials, chemical pharmaceutical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, Chinese medicine formulas, etc., with more than 3000 customers, covering all provinces, cities and autonomous regions of the country. The sales network covers Hangzhou, Ningbo, Wenzhou, Taizhou, Jinhua, Lishui, Fuzhou, Ningde, Fu'an, Tuorong, etc. It is responsible for the storage and emergency supply of medical equipment for epidemic and disaster prevention in Zhejiang Province, and is one of the three designated medical equipment storage enterprises in Zhejiang Province. Nearly 1000 employees of the group company (including close layer subsidiaries) work hard to implement the adjustment, approval, zero integration, intensive, chain and diversified operation of pharmaceutical products. There are 8 functional departments, 5 Pharmaceutical branches and 3 wholly-owned subsidiaries. It has "laoxiangshan", "Luwei" and other registered brands and good reputation. After more than 50 years of rapid development, the group company has become a large state-owned trading enterprise with strong economic strength, comprehensive management ability and pharmaceutical strength. Based on the enterprise spirit of "unity, truth-seeking, high quality, high efficiency and innovation", facing the future, the group will continue to enhance the independent innovation ability of the enterprise, strive to build the aircraft carrier of Wenzhou pharmaceutical business, further enhance the comprehensive competitiveness, and actively make new contributions to the practice and development of Wenzhou, enhance its strength and build a harmonious Wenzhou!

本文链接: https://brand.waitui.com/77af7415a.html 联系电话:057788223755

千城特选小程序码

7×24h 快讯

美股大型科技股盘前多数下跌,谷歌跌超7%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,谷歌跌超7%,亚马逊、苹果跌超1%,特斯拉跌0.92%,微软跌0.36%,Meta跌0.35%,奈飞跌0.14%;英伟达涨近1%。

2小时前

热门中概股美股盘前多数走弱,拼多多跌超7%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,拼多多跌超7%,理想汽车、微博跌超3%,阿里巴巴、京东、百度、蔚来跌超2%,小鹏汽车、爱奇艺跌超1%;B站涨超1%。

2小时前

君实生物:AWT020注射用无菌粉末临床试验申请获批

36氪获悉,君实生物公告,近日,公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,AWT020注射用无菌粉末(项目代号“JS213”)的临床试验申请获得批准。JS213是PD-1和白细胞介素-2双功能性抗体融合蛋白,主要用于晚期恶性肿瘤的治疗。

2小时前

渣打集团任命Maria Ramos接替韦浩思担任集团主席

2月4日,渣打集团董事会宣布,鉴于韦浩思(José Viñals)已接近他服务满9年的任期,已任命Maria Ramos(65岁)接替韦浩思担任集团主席。待取得监管批准后,Maria将于公司在2025年5月8日举行的2025年股东周年大会后履新,而韦浩思届时将自董事会退任。(界面)

2小时前

三六零:公司暂未向DeepSeek提供任何服务

36氪获悉,三六零公告,公司股票于2025年1月24日、1月27日、2月5日连续三个交易日内收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情形。经自查,公司注意到相关平台将公司股票纳入DeepSeek概念股。公司就相关事项澄清说明如下:在DeepSeek基于MIT开源协议的生态环境下,公司旗下的部分产品进行了DeepSeek的接入与本地化部署;公司暂未向DeepSeek提供任何服务。除上述事项外,公司未发现其他可能对公司股票交易价格产生较大影响的、需要公司澄清或回应的媒体报道或市场传闻

2小时前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询